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Cytotoxic polyfunctionality 
maturation of cytomegalovirus-
pp65-specific CD4 + and 
CD8 + T-cell responses in older 
adults positively correlates with 
response size
Yen-Ling Chiu1,2,3, Chung-Hao Lin4, Bo-Yi Sung1,5, Yi-Fang Chuang6, Jonathan P. Schneck1, 
Florian Kern7, Graham Pawelec8 & George C. Wang9
Cytomegalovirus (CMV) infection is one of the most common persistent viral infections in humans 
worldwide and is epidemiologically associated with many adverse health consequences during aging. 
Previous studies yielded conflicting results regarding whether large, CMV-specific T-cell expansions 
maintain their function during human aging. In the current study, we examined the in vitro CMV-
pp65-reactive T-cell response by comprehensively studying five effector functions (i.e., interleukin-2, 
tumor necrosis factor-α, interferon-γ, perforin, and CD107a expression) in 76 seropositive individuals 
aged 70 years or older. Two data-driven, polyfunctionality panels (IL-2-associated and cytotoxicity-
associated) derived from effector function co-expression patterns were used to analyze the results. We 
found that, CMV-pp65-reactive CD8 + and CD4 + T cells contained similar polyfunctional subsets, and 
the level of polyfunctionality was related to the size of antigen-specific response. In both CD8 + and 
CD4 + cells, polyfunctional cells with high cytotoxic potential accounted for a larger proportion of 
the total response as the total response size increased. Notably, a higher serum CMV-IgG level was 
positively associated with a larger T-cell response size and a higher level of cytotoxic polyfunctionality. 
These findings indicate that CMV-pp65-specific CD4 + and CD8 + T cell undergo simultaneous cytotoxic 
polyfunctionality maturation during aging.
Human cytomegalovirus (CMV) is a common beta human herpesvirus with an estimated infection prevalence 
of more than 50% of the world population1. After primary infection, which frequently occurs during early child-
hood, CMV establishes lifelong latency. While CMV was originally thought to be a harmless viral infection in 
immunocompetent individuals, others and we have shown that CMV seropositivity is in fact associated with 
many adverse consequences during normal aging2–4. For example, it is associated with an increased risk for hyper-
tension5, cardiovascular diseases6,7 and mortality4,8–10 and considered by some to be a causative agent. CMV 
infection may also be associated with unresponsiveness to influenza vaccination11.
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Both CD4 + and CD8 + T cells are required to control CMV infection1,12,13. While a healthy immune system 
is usually able to contain CMV and prevent it from causing overt clinical diseases (although CMV-reactivations 
causing mild symptoms may often be overlooked or not identified as caused by CMV), over time the virus acts 
as an enormous burden on the immune system. It is estimated that about 9-10% of the human memory T-cell 
compartment recognizes CMV-derived epitopes14. The number can be dramatically higher in the elderly15–17, 
possibly resulting from chronic antigenic stimulation caused by intermittent, subclinical reactivations of the virus 
throughout the lifetime. Such an accumulation of CMV-specific memory T cells may be maintained through a 
continuous replacement of short-lived, functional T cells18 and/or accumulation of apoptosis-resistant late-stage 
differentiated or “senescent” T cells19.
In many infectious diseases, immunological control of pathogens including CMV has been associated 
with the emergence of polyfunctional T cells capable of executing multiple effector functions20–23. In contrast, 
less-polyfunctional, or even “exhausted” T cells may dominate immune responses during chronic infections, 
such as those by human immunodeficiency virus24 and hepatitis C virus25. These T cells are characterized by a 
progressive loss of effector functions and, hence, loss of polyfunctionality, coupled with clonal expansion, and 
possibly replicative senescence26. Similarly, CMV-specific T cells undergo significant clonal expansion, especially 
in older adults16,27,28. It has been suggested that clonal expansion of CMV-specific T cells in the elderly negatively 
impacts on their functionality, as a limited number of studies enrolling older adults17,19 showed that a greater pro-
portion of CMV-pp65-specific T cells do not produce IFNγ in response to antigen stimulation. However, only one 
effector function was analyzed in these studies and potential variations in polyfunctionality among individuals 
with varying degrees of clonal expansion was not studied. In contrast, study performed in aged rhesus macaques 
showed that CMV-specific immunity is maintained and the response to and protection against an in vivo CMV 
challenge was identical in adult and aged macaques29. A recent human study30 performed in a cohort of diverse 
age showed that CMV-specific total response size positively correlated the frequencies of certain polyfunctional 
subsets. Nevertheless, the study included few older adults and the polyfunctionality markers were limited. It 
lacked important cytotoxicity measurements, in particular perforin and CD107a. It remains unclear whether any 
functional T-cell subset would preferentially expand in large CMV-specific responses, and whether CD4 + and 
CD8 + T cells undergo similar changes.
To answer these questions and gain further insight into the polyfunctional profiles of CMV-specific T cells 
during aging, we studied a comprehensive CMV-pp65-specific polyfunctionality signature in a cohort of adults 
aged 70 years or older. CMV-pp65 is an immunodominant protein that has a large impact on the T-cell reper-
toire in CMV-seropositive individuals31,32. In the present study, we defined CMV-pp65-specific polyfunctional 
responses by simultaneously measuring interleukin-2 (IL-2), tumor necrosis factor-α (TNFα ), interferon-γ 
(IFNγ ), CD107a, and perforin expression in both CD8 + and CD4 + T cells. Because IL-2 and perforin were 
found to be mutually exclusive functions, we analyzed polyfunctionality using either an IL-2-associated poly-
functionality panel (co-expression of IL-2, TNFα , and IFNγ ) or a cytotoxicity-associated polyfunctionality panel 
(co-expression of TNFα , IFNγ , CD107a, and perforin). We found that CD4 + and CD8 + CMV-pp65-specific 
T cells were dominated by the same functional subsets. For both CD8 + and CD4 + CMV responses, a higher 
degree of cytotoxicity-associated polyfunctionality positively correlated with a larger total CMV-specific response 
size. In contrast, IL-2-associated polyfunctionality did not follow the same trend. Although IL-2-associated 
polyfunctionality in CD8 + T cells was lower in large CMV responses, IL-2-associated polyfunctionality in 
CD4 + T cells was not dependent on response size. Finally, T-cell polyfunctionality and response size were pos-
itively correlated with serum CMV-IgG level. These findings suggest that, even in older adults, both CD8 + and 
CD4 + CMV-pp65-specific T cells do not undergo functional exhaustion in large CMV-specific responses, and 
the degrees of T-cell polyfunctionality positively correlate with the intensity of the humoral response against 
CMV.
Methods
Study participants. Heparinized venous whole blood was obtained from immunocompetent individuals 
not taking immunomodulatory pharmaceutical agents. A total of 76 CMV-seropositive elderly donors (55% 
female, 45% male) were included in this study. The age range was 71 to 93 years (mean age + /− standard devi-
ation, 80 + /− 5.7 years). The study protocol conforms to the Declaration of Helsinki and was approved by the 
institutional review board of Johns Hopkins University, Baltimore, MD. Informed consent was obtained from all 
participants.
Measurement of CMV IgG level. CMV IgG concentration was measured in stored (− 70 °C) serum spec-
imens using a commercial enzyme-linked immunosorbent assay kit (GenWay Biotech). Seropositivity for CMV 
was defined according to the manufacturer’s instructions, as a serum IgG concentration of > 1.2 IU/ml.
Cell preparation and peptide pool stimulation. The following protocol is prepared according to the 
MIATA (Minimal Information About T cell Assays) recommendations (www.miataproject.org). Briefly, periph-
eral blood mononuclear cells (PBMCs) were collected from each donor’s whole blood by density gradient centrif-
ugation (GE Healthcare Ficoll-Paque PLUS), resuspended in supplemented RPMI media containing 10% DMSO 
before cryopreserved in liquid nitrogen. Before use for stimulation, frozen PBMCs were thawed quickly in 37 °C, 
washed twice with complete RPMI medium, and rested overnight in complete RPMI medium containing 10% 
fetal bovine serum and 10μ g/ml DNase I (Sigma).
PBMCs were stimulated at a density of 1 million per 100 μ l of complete RPMI medium in a 96-well U bottom 
plate using a CMV-pp65 peptide pool containing 138 peptides derived from a peptide scan (15mers with 11 
amino acids overlap) of the 65kDa phosphoprotein (Swiss Protein ID: P06725) of human CMV. Cells were incu-
bated with the CMV-pp65 peptide pool (1μ g/ml per peptide, PepMix, JPT Peptide Technologies), anti-CD28/
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CD49d (BD Biosciences), anti-CD107a (BD, clone H4A3), Golgistop (monensin, BD), and Golgiplug (Brefeldin 
A, BD) for six hours at 37 °C.
Intracellular cytokine assay and polyfunctionality analyses. At the end of stimulation, cells were 
washed with FACS washing buffer and stained with anti-CD3 BV510 (clone OKT3, Biolegend), anti-CD8 
APC-Cy7 (clone RPA-T8, Biolegend), anti-CD4 Pacific Blue (clone SK3, Biolegend) and Live/Dead® cell via-
bility assay (Invitrogen) for 20 minutes before fixation with Cytofix/Cytoperm buffer (BD Biosciences) over-
night at 4 °C. On the next day, cells were washed with 1X Perm/Wash solution (BD Biosciences) and stained 
with anti-perforin-PE (clone B-D48, Biolegend), anti-IL-2-PerCP-Cy5.5 (clone MQ1-17H12, Biolegend), 
anti-TNFα -PE-Cy7 (clone Mab11, Biolegend), anti-IFNγ -APC (clone 25723.11, BD), at 4 °C for two hours. After 
washing, cytokine responses were acquired immediately using a BD LSRII flow cytometer.
Flow cytometry results were analyzed using FlowJo (Tree Star). A lymphocyte gate based on FSC/SSC, a singlet 
gate, and a live/dead cell gate were applied before gating on CD3 + CD8 + and CD3 + CD4 + cells. Subsequently, 
a population positive for each cytokine/effector function was gated. To obtain co-expression pattern, a combi-
natorial gating strategy based on the gates of each effector function was applied using the FlowJo Boolean gate 
platform. After subtracting the background response (with co-stimulation but no peptide antigen), a positive 
cytokine response was defined as at least 0.03% of CD3 + T cells and at least 40 events33. Total CMV-pp65-specific 
T-cell response was derived by summing the percentages of cells expressing at least one effector function among 
all CD8 + or CD4 + T cells (%CD8 + or %CD4 + ).
Statistical analyses. Simplified Presentation of Incredibly Complex Evaluations (SPICE, National Institutes 
of Health, available at http://www.niaid.nih.gov/) was used to analyze polyfunctionality profiles. A polyfunc-
tionality profile was first created using all five effector functions. To create the IL-2-associated polyfunctionality 
profile, the ability of cells to upregulate CD107a and perforin was excluded using the “sum” function. Similarly, 
to create the cytotoxicity-associated polyfunctionality profile, the signal of IL-2 production was excluded. 
Permutation tests set at 10,000 repetitions were used to test the differences between pie charts. Other statistical 
analyses were performed using Prism 5 (Graph Pad). For comparison between two groups of samples with para-
metric distribution (such as cytokine MFI), Student’s t-test was used. For comparison between two groups of sam-
ples with non-parametric distribution, non-parametric Mann-Whitney U test was used. Spearman’s rank-order 
correlation test was used to detect significant correlations between two parameters of interest.
Results
Polyfunctional response patterns of CD8 + and CD4 + T cells to CMV-pp65 peptide pools are 
similar. For the purpose of modeling CMV-specific T-cell polyfunctionality in this study, PBMCs were stimu-
lated with a CMV-pp65 peptide pool and analyzed for intracytoplasmic IL-2, TNFα , IFNγ , CD107a, and perforin 
expression. IFNγ , TNFα , and CD107a are typical CD8 + effector functions used to characterize virus-specific 
T-cell function20,24,34. IL-2 is typically expressed in memory T cells in the early differentiation stage. The ability 
of CMV-specific T cells to produce IL-2 has been implicated in protection against CMV-related disease23,35. In 
contrast, perforin is expressed in highly active effector T cells that do not produce IL-236. Upon antigen stimula-
tion, human T cells rapidly upregulate perforin de novo, which is immediately transported to the immunological 
synapse where it potentiates cytotoxicity37,38. We adopted the gating strategy reported by Makedonas et al38 to 
identify CMV-specific T cells capable of rapid perforin upregulation and used upregulation of perforin as one of 
the effector functions in this study.
After background subtraction, 66 of 76 CMV-seropositive individuals (86.8%) showed positive cytokine 
response. Figure 1A depicts representative flow cytometry staining results from an individual with both 
CD8 + and CD4 + T-cell responses. Total CMV pp65-specific response size defined as the frequency of cells 
capable of at least one effector function, was higher for CD8 + than CD4 + T cells (mean value, 0.38% vs. 0.14%). 
When individual effector functions were analyzed among the total functional responses, the proportion of cells 
with any cytotoxic function (CD107a or perforin upregulation) was higher among CD8 + than CD4 + T cells 
(93.7% versus 72.1%, p value = 0.013). In contrast, the proportion of cells producing IL-2 was higher among 
CD4 + than CD8 + T cells (19% versus 4.6%, p value < 0.001).
When the total response was further delineated by using all 31 possible functional combinations, we found 
that there were no cells capable of all of five functions assessed (Fig. 1B). This is due to the fact that IL-2 and 
perforin upregulation were mutually exclusive functions, consistent with findings from an earlier study36. 
The polyfunctionality profile pie chart (showing the relative contribution of each functional subset among 
the total functional responses) was very similar between CD8 + and CD4 + T cells (Fig. 1B). In addition, the 
same polyfunctional subsets were dominant in both CD8 + and CD4 + T cells. As shown in Fig. 1C,D, both 
CD8 + and CD4 + CMV-pp65-specific T cells contained a polyfunctional subset with high cytotoxic poten-
tial (IFNγ + TNFα + CD107a + perforin + IL-2- [I + T + C + P + 2- subset]), as well as clearly detectable IFN
γ + TNFα + CD107a + perforin-IL2 + (I + T + C + P-2 + ) and IFNγ + TNFα + CD107a + perforin-IL-2- 
(I + T + C + P-2-) subsets.
Polyfunctional CMV-pp65-specific cells have enhanced effector functions. While highly poly-
functional CMV-specific T cells are by definition capable of more types of effector functions than less polyfunc-
tional cells, it has also been shown that the former perform a given function as well as or superior to the latter22. 
Nevertheless, numerical differences between polyfunctionality levels (for example, three functions versus four 
functions) are still misleading in their specificity and unclear in their biological meaning. We thus looked at 
the expression level of IFNγ and TNFα in pp65-specific T cells within different polyfunctional subsets (Fig. 2). 
Clearly, the I + T + C + P-2 + subset in either CD8 + or CD4 + cells produced the highest level of IFNγ or TNFα . 
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While also being four-function capable, the I + T + C + P + 2- subset produced fewer effector cytokines on a 
per-cell basis than the I + T + C + P-2 + subset, with a level similar to the tri-functional I + T + C + P-2- sub-
set. Bi-functional and monofunctional cells have even lower expression levels of IFNγ and TNFα . In summary, 
while polyfunctional T cells in general have enhanced cytokine functions compared with oligofunctional T cells, 
cytokine expression levels differ among T-cell subsets capable of the same number of functions, such as the 
four-functional I + T + C + P-2 + and the four-functional I + T + C + P + 2- subsets.
IL-2-associated polyfunctionality and cytotoxicity-associated polyfunctionality among 
CMV-pp65-specific CD8 + T cells. Because some previous studies suggested that the CD8 + CMV-specific 
T-cells accumulating in the elderly were in some respects dysfunctional19,27, we asked whether CMV-specific 
T cells would differ in the degree of polyfunctionality among individuals with different total CMV-specific 
response sizes. As IL-2 and perforin expression is mutually exclusive, we investigated the change in polyfunc-
tionality in relation to total response size according to two different combinations (panels) of cellular expres-
sion: IL-2-associated polyfunctionality was analyzed using the functional combination of IL-2, IFNγ , and TNFα 
expression (Fig. 3A), while cytotoxicity-based polyfunctionality was analyzed using the functional combination 
Figure 1. Polyfunctionality profiles of CD8 + and CD4 + CMV-specific T cells in older adults are similar. 
A comprehensive profile of CMV-pp65-specific T-cell function, including IL-2, TNFα , IFNγ , CD107a, and 
perforin, was analyzed in a cohort of older donors. (A) Representative results of flow cytometry staining 
of CMV-specific effector functions. The plots are obtained from a donor with moderately sized CD8 + and 
CD4 + responses. (B) Pie charts demonstrating the relative contribution of each of 31 possible functional 
subsets among the total CD8 + or CD4 + response in all participants. An accompanying bar graph depicting 
the average frequency of each functional subset among the CD8 + or CD4 + population is shown in 
Fig. 1C,D. (C,D) Frequency of each CMV-specific functional subset among CD8 + (C) or CD4 + (D) T cells 
in all participants. The landscapes of the functional subsets were remarkably similar between CD8 + and 
CD4 + cells. In both CD8 + and CD4 + T cells, the IFNγ + TNFα + CD107a + perforin + IL-2- subset and the 
IFNγ + TNFα + CD107a + perforin-IL-2- subset dominated the response.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:19227 | DOI: 10.1038/srep19227
of IFNγ , TNFα , CD107a, and perforin expression (Fig. 3B). Besides the polyfunctionality profile, which portrays 
the relative contribution of each T-cell functional subset, we also focused on the frequency of the most poly-
functional T-cell subset in each panel: the I + T + 2 + subset and the I + T + C + P + subset, for the subsequent 
analyses.
We first separated the participants into three groups based on their total CMV-specific CD8 + T-cell response 
size (%CD8 + ) defined as follows: large, > 1%; medium, 0.5-1%; and small, < 0.5%. As shown in the bar graphs 
in Fig. 3A and Fig. 3C, the frequency of CMV-pp65-specific I + T + 2 + polyfunctional CD8 + T cells (%CD8 + ) 
increased as the total CMV-pp65-specific CD8 + T-cell response size increased. The relationship between the 
frequency of pp65-specific I + T + C + P + polyfunctional CD8 + T cells and total pp65-specific CD8 + T-cell 
response size also followed the same trend (bar graphs in Fig. 3B and Fig. 3E). These findings suggest that expan-
sions of both of these polyfunctional CD8 + T-cell subsets occurred as total response size increased.
Although both polyfunctional CD8 + T-cell subsets accumulated (increased their frequencies among 
CD8 + T cells) in relation to increased total response size, the CD8 + T-cell polyfunctionality profile, reflect-
ing the relative contribution of each polyfunctional subset to the total response, is significantly different among 
different total response sizes. Specifically, as shown in Fig. 3A (pie charts) and Fig. 3D, the proportions of the 
CD8 + , I + T + 2 + T-cell subset among total responses significantly decreased as total response size increased. 
In contrast, the proportion of the CD8 + , cytotoxic I + T + C + P + T-cell polyfunctional subset increased as 
total response size increased (Fig. 3B pie charts, Fig. 3F). Thus, depending on the polyfunctionality panel being 
considered, the pp65-specific CD8 + T-cell response can be either relatively more polyfunctional (cytotoxicity 
response) or less polyfunctional (IL-2-associated response) with larger total response size.
IL-2-associated polyfunctionality and cytotoxicity-associated polyfunctionality among 
CMV-pp65-specific CD4 + T cells. We also performed similar polyfunctionality analyses on CD4 + T cells 
(Fig. 4). Samples were separated into two groups instead of three based on CD4 + T-cell response size because 
Figure 2. Polyfunctional T cells exhibit enhanced effector functions. Five CMV-pp65-specific functional 
subsets within CD8 + (A,B) or CD4 + (C,D) T cells were compared with respect to their mean fluorescence 
intensity (MFI) of TNFα and IFNγ staining. I, IFNγ ; T, TNFα ; C, CD107a; P, perforin; 2, IL-2. (A,B) In 
CD8 + T cells, the I + T + C + P-2 + subset displayed the strongest staining for IFNγ and TNFα when 
compared with the I + T + C + P + 2- and the I + T + C + P-2- subset. The dual functional, I + T + C-P-2- 
subset and the monofunctional, I + T-C-P-2- or I-T + C-P-2- subset produced even lower levels of IFNγ and 
TNFα . (C,D) Higher MFIs for IFNγ and TNFα in polyfunctional subsets were also observed in CMV-specific 
CD4 + T cells. The comparisons were carried out individually by paired Student’s t-test. The threshold for 
statistical significance was corrected following the Bonferroni method. NS: non-significant; *p value < 0.007; 
**p value < 0.0007.
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the overall response size was smaller for CD4 + T cells: large, > 0.3%; and small, < 0.3%. Overall, compared 
with CMV-pp65-specific CD8 + T-cell responses, CMV-pp65-specific CD4 + T cells had a higher propor-
tion of cells capable of IL-2 expression and a lower proportion capable of cytotoxic functions. Consistent with 
the observations made for the CD8 + T-cell population, the frequencies of both I + T + 2 + and the cytotoxic 
I + T + C + P + populations were higher in large CD4 + T cell responses, the latter also representing a larger 
proportion of the activated cells. However, unlike in CD8 + T cells, the proportion of the I + T + 2 + subset 
was the same in large and small CD4 + T cell responses. In summary, both CD8 + and CD4 + pp65-specific T 
cells undergo progressive cytotoxicity-associated polyfunctionality maturation in older adults with expanding 
CMV-specific responses.
Figure 3. The size of the total CMV-specific CD8 + T-cell response determines its polyfunctionality profile. 
Based on the total frequency (%CD8+ ) of CMV-reactive cells among CD8 + T cells (or total response, TR), 
participants were separated into three response-size groups: large, > 1%; medium, 0.5–1%; and small, < 0.5%. 
Polyfunctionality was analyzed according to two different combinations (panels) of cellular expression. The 
first panel consisted of three cytokine effector functions associated with memory T cells: IL-2 (2), TNFα (T), 
and IFNγ (I) (Panel A). The second panel consisted of four effector functions associated with the cytotoxic 
effector phenotype: perforin (P), CD107a (C), TNFα (T) and IFNγ (I) (Panel B). Results are summarized 
using pie charts (showing the relative contribution of each functional subset among the total response) and bar 
graphs (showing the frequency of each functional subset within total CD8 + cells, %CD8). Each color slice of 
the pie chart corresponds to a specific functional subset shown in the corresponding bar graph. For simplicity, 
some subsets without any cells are hidden from the bar graphs. (A) Large, medium, and small TRs harbored 
different levels of IL-2-associated polyfunctionality. The I + T + 2 + subset represented a smaller proportion 
of the TR (shown as the red slice in the pie charts) in the large than smaller TRs. However, the frequency of the 
I + T + 2 + subset within total CD8 + T cells (%CD8) was higher in participants with larger TRs. (B) Different 
TR sizes harbored different levels of cytotoxic polyfunctionality. The I + T + C + P + subset constituted a larger 
proportion of the large TR than it did in the small TR. The large TR at the same time also comprised a higher 
frequency of I + T + C + P + cells within total CD8 + T cells (%CD8) (shown as the red slice in pie charts). (C) 
Linear regression analysis showed that the I + T + 2 + subset frequency (%CD8) positively correlated with TR 
size. (D) However, the proportion of I + T + 2 + subset within TR negatively correlated with TR size. (E,F) Both 
the I + T + C + P + subset frequency (%CD8) and its proportion within TR positively correlated with TR size.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:19227 | DOI: 10.1038/srep19227
Relationships among pp65-specific T-cell response size, polyfunctionality, and serum CMV 
IgG level. It is known that CMV-specific T-cell response size is highly variable among individuals. Previous 
studies have shown that certain HLA types can affect pathogen-specific T-cell frequency and functions39,40. 
In addition, a large response size could also result from more frequent viral reactivations in vivo and thus 
greater expansion of antigen-specific cells. To better understand the relationships between the CMV-specific 
humoral response in vivo and the CD4 + and CD8 + cellular response in vitro, we first examined the relation-
ship between CMV-pp65-specific CD8 + and CD4 + T-cell responses. We found that the total pp65-specific 
CD8 + and CD4 + T-cell responses were positively correlated (R = 0.347, p value = 0.0053; Table 1). Further, 
both pp65-specific CD8 + and CD4 + total response sizes were positively correlated with serum CMV IgG level. 
Because CMV IgG antibody titer has been found to increase linearly with the level of viremia and viral load in 
leukocytes41,42, the current findings support the notion that a large CMV-specific T-cell response size reflects 
more frequent and/or more severe viral reactivations in these older individuals.
Given the significant correlation between total response size and polyfunctionality (Figs 3 and 4), we also exam-
ined the relationship between polyfunctionality and total response size across CD4 + and CD8 + T-cell responses. 
Figure 4. Size of the CMV-specific CD4 + T-cell response determines cytotoxic but not IL-2-associated 
polyfunctionality profile. Based on the total frequency (%CD4 + ) of CMV-reactive cells among CD4 + T 
cells (or total response, TR), participants were separated into either the large (> 0.3%) or small (< 0.3%) TR 
group. Polyfunctionality was analyzed as described in Fig. 3. The first panel consisted of three cytokine effector 
functions associated with young memory T cells: IL-2 (2), TNFα (T), and IFNγ (I) (Panel A). The second panel 
consisted of four effector functions associated with the cytotoxic effector phenotype: perforin (P), CD107a (C), 
TNFα (T) and IFNγ (I) (Panel B). (A) Large and small TRs harbored similar IL-2-associated polyfunctionality. 
The I + T + 2 + subset represented a non-significantly smaller proportion of total TR (shown as the red slice in 
the pie charts) in large than small TR. However, the frequency of the I + T + 2 + subset within total CD4 + T 
cells (%CD4) was higher in participants with large than small TR. (B) Different TR sizes harbored different 
levels of cytotoxic polyfunctionality. Large TR contained a higher proportion of the I + T + C + P + subset 
than small TR. Individuals with large TR also had a higher frequency of I + T + C + P + cells (%CD4) (shown 
as the red slice in the pie charts). (C) Linear regression analysis showed that the I + T + 2 + subset frequency 
(%CD4) positively correlated with TR size. (D) Consistent with the observation in (A), the proportion of the 
I + T + 2 + subset was not correlated with TR size. (E,F) Both the I + T + C + P + subset frequency (%CD4) 
and its proportion within TR positively correlated with TR size. Overall, the results suggest that the expansion 
of CMV-specific CD4 + T cells is associated with progressive cytotoxic effector function maturation.
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Interestingly, we found that the frequency of CD8 + cytotoxic polyfunctional T cells (%CD8 + , T + I + C + P + ) 
was positively correlated with the total CD4 + T-cell response size, while the frequency of CD4 + IL-2-associated 
polyfunctional T cells (%CD4 + , I + T + 2 + ) was positively correlated with the total CD8 + response size. 
Notably, the degree of CD8 + cytotoxic polyfunctionality positively correlated with CD4 + T-cell polyfunctional-
ity and the level of CMV IgG positively correlated with the level of CD4 + and CD8 + cytotoxic polyfunctionality 
(Fig. 5). Overall, these results suggest that the humoral response is closely related to the clonal expansion and 
cytotoxic polyfunctionality maturation of both CD4 + and CD8 + CMV-specific T cells in older adults.
Discussion
Some published reports have associated the accumulation of CMV-specific, late-differentiated memory cells in 
older adults with impaired immune competence11,43,44 and argued that these contribute to the immunosenescent 
phenotype as well as the immune risk profile (IRP)2,3,45. Others, however, have reported that highly polyfunctional 
T cell subsets accumulate in such expanded responses30. While older adults are at higher risk of experiencing 
many infection-related illnesses, it is not yet clear whether established anti-viral immunity remains robust in 
Spearman R
95% confidence 
interval p value
Correlation with total CMV-specific CD8 + T-cell response size
 CMV Ig level (IU/ml) 0.32 0.009 to 0.50 0.006*
  Total CMV-specific CD4 + T-cell response size 
(%CD4 + ) 0.35 0.10 to 0.55 0.005*
  CMV-specific CD4 + IL-2 polyfunctionality 
(I + T + 2 + %CD4 + ) 0.57 0.39 to 0.70 < 0.001*
  CMV-specific CD4 + cytotoxic 
polyfunctionality (T + I + C + P + %CD4 + ) 0.24 − 0.012 to 0.47 0.054
Correlation with total CMV-specific CD4 + T-cell size
 CMV Ig level (IU/ml) 0.23 0.029 to 0.44 0.049*
  CMV-specific CD8 + IL-2 polyfunctionality 
(I + T + 2 + %CD8 + ) 0.007 − 0.18 to 0.31 0.56
  CMV-specific CD8 + cytotoxic 
polyfunctionality (T + I + C + P + %CD8 + ) 0.32 0.082 to 0.53 0.008*
Correlation with total CMV IgG level (IU/ml)
  CMV-specific CD8 + IL-2 polyfunctionality 
(I + T + 2 + %CD8 + ) 0.21 − 0.04 to 0.43 0.094
  CMV-specific CD8 + cytotoxic 
polyfunctionality (T + I + C + P + %CD8 + ) 0.34 0.15 to 0.55 0.001*
  CMV-specific CD4 + IL-2 polyfunctionality 
(I + T + 2 + %CD4 + ) 0.15 − 0.10 to 0.38 0.146
  CMV-specific CD4 + cytotoxic 
polyfunctionality (T + I + C + P + %CD4 + ) 0.35 0.13 to 0.53 0.002*
Table 1.  Close relationships among CMV IgG level, total pp65-specific T-cell response size, and 
cytotoxic polyfunctionality. Spearman’s rank-order correlation test was used to detect significant correlations 
between two parameters of interest. CMV-IgG level showed significant positive associations with CD4 + and 
CD8 + cytotoxic polyfunctional cell frequencies.
Figure 5. Cytotoxic T-cell polyfunctionality positively correlates with CMV-IgG level. (A) Cytotoxic 
CD4 + T-cell polyfunctionality positively correlated with cytotoxic CD8 + T-cell polyfunctionality. (B,C) Level 
of CMV-IgG positively correlated with CD8 + and CD4 + T-cell cytotoxic polyfunctionality. Spearman’s rank-
order correlation test was used to detect significant correlations between two parameters of interest.
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older age or gradually becomes exhausted. Indeed, recent evidence suggests that virus-specific T cell polyfunc-
tionality does not decrease with age46. However, limited longitudinal studies have associated a loss of predom-
inantly CMV-specific CD8 + T cell clonal expansions with incipient mortality in the very elderly27. In order to 
gain better insight into how the immune system controls CMV infection and how this may contribute to the 
immunosenescent phenotype, further studies are required.
In the current study, we performed a comprehensive analysis of the CMV-pp65-reactive polyfunctionality 
landscape in older adults by simultaneously measuring five T-cell effector functions and analyzing the results 
according to two combinations of cytokine co-expression pattern. To further build on findings from previous 
studies, we adopted a unique, data-driven approach to analyzing the complete landscape of anti-CMV-pp65 T-cell 
polyfunctionality response. Because IL-2 and perforin were mutually exclusive functions, we analyzed the poly-
functionality profile by two different panels. We demonstrated that in older adults, both CMV-pp65-specific 
CD4 + and CD8 + T-cell responses were dominated by the same functional subsets, i.e., T cells simultaneously 
expressing TNFα , IFNγ , and CD107a but not IL-2 or perforin, and T cells simultaneously expressing TNFα , 
IFNγ , CD107a, and perforin but not IL-2. Most importantly, we showed that CMV-pp65-specific T cells in older 
adults did not undergo functional exhaustion even in large responses. Instead, these cells exhibited evidence of 
greater cytotoxicity-associated polyfunctionality maturation into an “effector”-like phenotype in larger response 
sizes. The frequency (%CD8 + or %CD4 + ) of TNFα + IFNγ + CD107a + perforin + IL2- polyfunctional T cells 
was higher among larger total response sizes, in both CD8 + and CD4 + populations. Clearly, polyfunctional 
cells were not superseded by less polyfunctional cells in large CMV-specific T-cell responses, even in the elderly. 
These findings appear to refute those of several previous studies19,27, which suggested that clonally expanded 
CMV-specific T cells are to some extent dysfunctional in older adults. However, in those studies, CMV-specific 
T-cell function was only analyzed based on a combination of tetramer staining and IFNγ production, with-
out measuring other effector functions. In our study, T cell function was probed without tetramer staining, 
thus direct comparison between studies is not possible. Although we can not exclude the possibility that cer-
tain pp65-specific cells may not have any effector function thus will not be detected by our assay, using tetram-
ers to identify antigen-specific cells will only narrow the repertoire of response in general we are interested in. 
Furthermore, we believe the combination of tetramer staining along with peptide stimulation potentially could 
be biased because tetramers inevitably compete with the added peptide for T-cell receptor binding, and the meas-
ured level of polyfunctionality could be severely affected. Nevertheless, in future studies, it maybe possible to use 
certain activation markers such as CD137, CD69 and CD40L to identify antigen-specific cells.
The observation that polyfunctional cytotoxic T cells comprised a dominant population in both CD8 + and 
CD4 + CMV-pp65-specific T cells suggests that the expansion of polyfunctional cytotoxic T cells is the driving 
force for large response size in T-cell immunity against CMV. A larger proportion of cytotoxic polyfunctional 
cells among CMV-specific T cells was associated with a reciprocally smaller proportion of IL-2-producing poly-
functional cells among CMV-specific T cells in CD8 + T-cell but not in CD4 + T-cell responses. Because IL-2 
production is a feature of naïve and central memory cells and is the first function to be downregulated during 
progression towards a more differentiated phenotype47,48, pp65-specific CD4 + T cells may be less differentiated 
than their CD8 + counterparts. IL-2-producing CMV-specific T cells are implicated in preventing CMV-related 
clinical disease, including in transplant recipients23,49 and in HIV-infected patients35, and thus may also pro-
tect older adults from CMV-related acute illness. Our results showed that the frequencies of these cells within 
the total CD4 + and CD8 + T-cell populations did not decline but, rather, increased in individuals with larger 
CMV-specific responses. Such findings might explain why overt CMV-related acute illnesses are rare even in 
older adults and could represent a compensatory mechanism to maintain CMV immunosurveillance. This inter-
pretation is consistent with the earlier observations that although the frequency of functional IFNγ -producing 
CD8 + T cells carrying receptors for a CMV-pp65 epitope was lower in the elderly than the young, the accu-
mulation of these cells in the elderly resulted in higher absolute numbers of functional anti-CMV cells in older 
subjects19.
Research interest in polyfunctional cells has gained a strong momentum in the last decade, as a critical role of 
polyfunctional T cells in immunological control has been shown in both human and animal studies20,22,23,50. Our 
study provides a novel observation that polyfunctional T-cell response is associated with higher level of anti-viral 
antibody. In our previous publication42, we have found that level of anti-CMV antibody is positively associated 
with viral load and negatively associates with T-cell receptor repertoire diversity. Thus it is intriguing to study 
if repertoire diversity is related to polyfunctionality. However, the appropriate definition of polyfunctionality 
and its relation to clinical outcomes remain poorly understood. T cells with early memory features such as IL-2 
secretion and proliferation may be especially important in maintaining the antigen-specific T-cell population, 
but these cells are not capable of rapid perforin upregulation and efficient target cell killing. On the other hand, 
a definition of polyfunctionality without cytotoxic functions will not capture the complete picture of anti-viral 
cellular response. Our study indicates that different definitions of polyfunctionality are necessary and could lead 
to distinct relationships between polyfunctionality and total response size (Fig. 3). As a result, caution is needed 
when interpreting study results in the literature on T-cell polyfunctionality.
In summary, CD4 + and CD8 + CMV-pp65-specific T cells in older adults exhibit increasing polyfunction-
ality in association with increasing response size. Such changes in cytotoxic polyfunctionality maturation are 
positively related to the intensity of the humoral response. Our findings may not apply to all T-cell responses 
against other viruses and may not necessarily apply to other CMV viral proteins. However, our data support a 
model in which virus-specific CD4 + and CD8 + T cells synergistically contribute to the quantity and quality of 
the memory T-cell response during latent infection in aging. Further studies are required to determine whether 
CMV-specific T-cell polyfunctionality reflects the frequency and magnitude of prior episodes of viral reactiva-
tion, and whether it is associated with any significant clinical outcomes.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 6:19227 | DOI: 10.1038/srep19227
References
1. Crough, T. & Khanna, R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 22, 76–98, Table of 
Contents (2009).
2. Pawelec, G., McElhaney, J. E., Aiello, A. E. & Derhovanessian, E. The impact of CMV infection on survival in older humans. Curr 
Opin Immunol 24, 507–511 (2012).
3. Solana, R. et al. CMV and Immunosenescence: from basics to clinics. Immun Ageing 9, 23 (2012).
4. Savva, G. et al. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell (2013).
5. Cheng, J. et al. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog 5, e1000427 (2009).
6. Ji, Y. N., An, L., Zhan, P. & Chen, X. H. Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. Mol Biol Rep 39, 
6537–6546 (2012).
7. Courivaud, C. et al. Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients. J Infect Dis 207, 
1569–1575 (2013).
8. Roberts, E. T., Haan, M. N., Dowd, J. B. & Aiello, A. E. Cytomegalovirus antibody levels, inflammation, and mortality among elderly 
Latinos over 9 years of follow-up. Am J Epidemiol 172, 363–371 (2010).
9. Wang, G. C. et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort 
study. Am J Epidemiol 171, 1144–1152 (2010).
10. Simanek, A. M. et al. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the 
United States. PLoS One 6, e16103 (2011).
11. Derhovanessian, E. et al. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral 
response to influenza vaccination. Vaccine 31, 685–690 (2012).
12. Jeitziner, S. M., Walton, S. M., Torti, N. & Oxenius, A. Adoptive transfer of cytomegalovirus-specific effector CD4 + T cells provides 
antiviral protection from murine CMV infection. Eur J Immunol 43, 2886–2895.
13. Cantisan, S. et al. Pretransplant interferon-gamma secretion by CMV-specific CD8 + T cells informs the risk of CMV replication 
after transplantation. Am J Transplant 13, 738–745 (2013).
14. Sylwester, A. W. et al. Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory 
compartments of exposed subjects. J Exp Med 202, 673–685 (2005).
15. Khan, N. et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. 
J Immunol 169, 1984–1992 (2002).
16. Fletcher, J. M. et al. Cytomegalovirus-specific CD4 + T cells in healthy carriers are continuously driven to replicative exhaustion. J 
Immunol 175, 8218–8225 (2005).
17. Vescovini, R. et al. Massive load of functional effector CD4 + and CD8 + T cells against cytomegalovirus in very old subjects. J 
Immunol 179, 4283–4291 (2007).
18. van Lier, R. A., ten Berge, I. J. & Gamadia, L. E. Human CD8(+ ) T-cell differentiation in response to viruses. Nat Rev Immunol 3, 
931–939 (2003).
19. Ouyang, Q. et al. Dysfunctional CMV-specific CD8(+ ) T cells accumulate in the elderly. Exp Gerontol 39, 607–613 (2004).
20. Betts, M. R. et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8 + T cells. Blood 107, 4781–4789 
(2006).
21. Darrah, P. A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 
13, 843–850 (2007).
22. Seder, R. A., Darrah, P. A. & Roederer, M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev 
Immunol 8, 247–258 (2008).
23. Krol, L. et al. Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT. Bone Marrow 
Transplant 46, 1089–1098 (2010).
24. Migueles, S. A. et al. Defective human immunodeficiency virus-specific CD8 + T-cell polyfunctionality, proliferation, and 
cytotoxicity are not restored by antiretroviral therapy. J Virol 83, 11876–11889 (2009).
25. Rodrigue-Gervais, I. G. et al. Dendritic cell inhibition is connected to exhaustion of CD8 + T cell polyfunctionality during chronic 
hepatitis C virus infection. J Immunol 184, 3134–3144 (2010).
26. Wherry, E. J. T cell exhaustion. Nat Immunol 12, 492–499 (2011).
27. Hadrup, S. R. et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an 
increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 176, 2645–2653 (2006).
28. Pita-Lopez, M. L. et al. Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors. Immun Ageing 6, 11 
(2009).
29. Cicin-Sain, L. et al. Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques. J Immunol 187, 
1722–1732 (2011).
30. Lachmann, R. et al. Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses. J Virol 86, 
1001–1009 (2011).
31. Wills, M. R. et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: 
frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 70, 7569–7579 (1996).
32. Kern, F. et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-
exposed individuals. J Infect Dis 185, 1709–1716 (2002).
33. Riou, C. et al. Increased Memory Differentiation Is Associated with Decreased Polyfunctionality for HIV but Not for 
Cytomegalovirus-Specific CD8 + T Cells. J Immunol 189, 3838–3847 (2012).
34. Chiu, Y. L. et al. Sprouty-2 regulates HIV-specific T cell polyfunctionality. J Clin Invest 124, 198–208 (2014).
35. Sinclair, E. et al. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that 
express interferon- gamma and interleukin-2 and have a CD8 + cell early maturational phenotype. J Infect Dis 194, 1537–1546 
(2006).
36. Makedonas, G. et al. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human 
CD8 T cells. PLoS Pathog 6, e1000798 (2010).
37. Hersperger, A. R., Makedonas, G. & Betts, M. R. Flow cytometric detection of perforin upregulation in human CD8 T cells. 
Cytometry A 73, 1050–1057 (2008).
38. Makedonas, G. et al. Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a 
novel mechanism of antigen-specific CD8 + T cell cytotoxic activity. J Immunol 182, 5560–5569 (2009).
39. Bihl, F. et al. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance 
of virus-specific CTL responses. J Immunol 176, 4094–4101 (2006).
40. Harari, A. et al. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc Natl Acad 
Sci USA 104, 16233–16238 (2007).
41. van Zanten, J. et al. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection 
in lung transplantation as detected with recombinant and naturally occurring proteins. Clinical and diagnostic laboratory 
immunology 2, 214–218 (1995).
42. Wang, G. C., Dash, P., McCullers, J. A., Doherty, P. C. & Thomas, P. G. T cell receptor alphabeta diversity inversely correlates with 
pathogen-specific antibody levels in human cytomegalovirus infection. Sci Transl Med 4, 128ra142 (2012).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:19227 | DOI: 10.1038/srep19227
43. Cicin-Sain, L. et al. Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice 
with aging. PLoS Pathog 8, e1002849 (2012).
44. Trzonkowski, P. et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-
hemagglutinins during the anti-influenza vaccination—an impact of immunosenescence. Vaccine 21, 3826–3836 (2003).
45. Pawelec, G., Larbi, A. & Derhovanessian, E. Senescence of the human immune system. J Comp Pathol 142 Suppl 1, S39–44 (2009).
46. Lelic, A. et al. The polyfunctionality of human memory CD8 + T cells elicited by acute and chronic virus infections is not influenced 
by age. PLoS Pathog 8, e1003076 (2012).
47. Appay, V., van Lier, R. A., Sallusto, F. & Roederer, M. Phenotype and function of human T lymphocyte subsets: consensus and issues. 
Cytometry A 73, 975–983 (2008).
48. Sallusto, F., Geginat, J. & Lanzavecchia, A. Central memory and effector memory T cell subsets: function, generation, and 
maintenance. Annu Rev Immunol 22, 745–763 (2004).
49. Gimenez, E. et al. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8 T cells that are 
associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation. Transpl Infect Dis 17, 
361–370 (2015).
50. Park, S. H. et al. Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis 
C virus. Gastroenterology 143, 1048–1060 e1044 (2012).
Acknowledgements
The authors thank Dr. Hao Chang for his assistance with the multicolor flow cytometry. We also thank Dr. Joan 
Glick Bieler and Dr. Mathias Oelke for critical review of this manuscript. This work was supported by National 
Institutes of Health (NIH), National Institute on Aging (NIA) Grants K23 AG033113 and P30 AG021334 
(through the Johns Hopkins Older Americans Independence Center); T. Franklin Williams Research Scholars 
Award, sponsored by Atlantic Philanthropies, American Geriatrics Society, the John A. Hartford Foundation, 
and the Association of Subspecialty Professors; John A. Hartford Foundation’s Center of Excellence in Geriatric 
Medicine Scholars Award; the Johns Hopkins Biology of Healthy Aging Program; and Far Eastern Memorial 
Hospital grant FEMH-2015-C-007.
Author Contributions
Y.L.C., C.H.L. and B.Y.S. carried out experiments; Y.L.C., Y.F.C. and J.P.S. analyzed experiments; Y.L.C., B.Y.S., 
J.P.S. and G.W. designed experiments; F.K. and G.P. edited the manuscript; Y.L.C. and G.W. wrote the manuscript.
Additional Information
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Chiu, Y.-L. et al. Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-
specific CD4+ and CD8+ T-cell responses in older adults positively correlates with response size. Sci. Rep. 6, 
19227; doi: 10.1038/srep19227 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
